# Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)

> **NCT00092131** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 51 (actual)

## Conditions studied

- Asthma, Exercise-Induced

## Interventions

- **DRUG:** Comparator: Montelukast
- **DRUG:** Comparator: Placebo

## Key facts

- **NCT ID:** NCT00092131
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2003-11
- **Final completion:** 2003-11
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2022-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092131, "Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00092131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*